BW

Blue Water Life Science Fund

North America, California, United States, Mill Valley

Description

Blue Water Life Science Fund

Investor Profile

Blue Water Life Science Fund has made 7 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (29%)
  • Post Ipo Equity (29%)
  • Series C (29%)
  • Series E (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Health Diagnostics
  • Pharmaceutical
  • Life Science
  • Medical
  • Genetics
  • Mhealth
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Blue Water Life Science Fund frequently co-invest with?

Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 2
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 2
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 3
Casdin Capital
North America, New York, United States, New York
Co-Investments: 2
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 2
Jazz Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 2
Trustbridge Partners
North America, Massachusetts, United States, Boston
Co-Investments: 2
Co-Investments: 2

Which angels does Blue Water Life Science Fund often collaborate with?

JD
North America, California, United States, Menlo Park
Shared Deals: 1
MZ
North America, United States
Shared Deals: 1

What are some of recent deals done by Blue Water Life Science Fund?

Karius

Redwood City, California, United States

Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.

BiotechnologyGeneticsHealth CareInformation TechnologyLife SciencePrecision Medicine
Series CMay 2, 2024
Amount Raised: $100,000,000
Ansa Biotechnologies

Emeryville, California, United States

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

BiotechnologyLife ScienceTherapeutics
Series AApr 11, 2022
Amount Raised: $68,000,000
Visby Medical

San Jose, California, United States

Visby Medical is a diagnostics company that develops PCR-based diagnostic tests for the detection of infectious diseases.

Health CareHealth DiagnosticsMedical
Series EMar 1, 2022
Amount Raised: $100,000,000
Pear Therapeutics

Boston, Massachusetts, United States

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

BiotechnologymHealthPharmaceuticalSoftwareTherapeutics
Post Ipo EquityDec 6, 2021
Amount Raised: $125,000,000
NeoGenomics

Fort Myers, Florida, United States

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedicalPharmaceutical
Post Ipo EquityMay 5, 2021
Amount Raised: $200,000,000
SomaLogic

Boulder, Colorado, United States

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series ANov 25, 2020
Amount Raised: $121,000,000
Pear Therapeutics

Boston, Massachusetts, United States

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

BiotechnologymHealthPharmaceuticalSoftwareTherapeutics
Series CJan 4, 2019
Amount Raised: $64,000,000